News

New research has illustrated the role of the microbiome in conferring the heart health benefits of walnuts.

A parasite with devastating impacts on human health and agriculture is the first pathogen to have its proteins mapped within its cells, which could help to identify new drug targets.

Researchers at the Carbone Cancer Center have identified the cells that can cause graft versus host disease, the most common complication of bone marrow transplants.

High-performance microscopy has thrown light on the mechanisms behind how antibiotics stop bacterial growth.

A new study suggests that the number of “hidden” infections tied to a place, or cases of infected people who show no symptoms, is the key indicator for dengue risk.

The use of a monoclonal antibody that reduced circulating IgG levels, led to a decrease in preexisting neutralizing antibodies (NAbs) to adeno-associated virus (AAV).

Results from an animal study published in Science Translational Medicine demonstrate that a drug compound can disrupt overactivation of inflammation and manage pain and stiffness in osteoarthritis. The drug will be tested in upcoming Phase I and IIa clinical trials.

A new drug candidate – nitroxoline – for treating mpox has been identified, with clinical trials due to begin soon.

According to research, physical activity of moderate duration (over 2.5 hours per week) increased both the richness and diversity of the gut microbiomes compared to study participants that exercised less.

Understanding the interactions between plants and the microorganisms that live on their surfaces may help us develop agricultural management practices that can increase crop productivity and resilience.